A novel noninvasive score including LSM by VCTE™ and routine clinical parameters improves the identification of cirrhosis among patients with MASLD and may reduce the necessity of liver biopsy in this patient population.
A novel noninvasive score including LSM by VCTE™ and routine clinical parameters improves the identification of cirrhosis among patients with MASLD and may reduce the necessity of liver biopsy in this patient population.
Melden Sie sich für unsere Mailingliste an, um Aktualisierungen zu Artikeln zu erhalten, White Papers und dokumentarische Webinare für Management und Behandlung chronischer Lebererkrankungen.